Ranked as India's No1 Genetic Testing Lab

Pancreatic cancer panel targeted APC ATM BMPR1A CDKN2A EPCAM MLH1 MSH2 MSH6 PALB2 PMS1 PMS2 PRSS1 SMAD4 STK11

5 out of 5 based on 50000 customers ratings
(50000 customers reviews)

55000

/- Rs.

Product Description

Sample Type: EDTA Blood 3ml, One drop Blood FTA Card, Swabs, 2 uml DNA

Reporting Time: 6 Weeks

Pancreatic cancer panel targeted APC ATM BMPR1A CDKN2A EPCAM MLH1 MSH2 MSH6 PALB2 PMS1 PMS2 PRSS1 SMAD4 STK11 genes will be analysed by PCR and next-generation sequencing of both DNA strands of the entire coding region and the highly conserved exon-intron splice junctions. PCR-based amplicon library capture will be utilized. We have a minimum coverage of 30x for every amplicon.

Next Generation Sequencing (NGS) technologies have emerged as a powerful tool for the discovery of causative mutations in rare Mendelian disease genes and are rapidly impacting genetic diagnostics. NGS technologies can be used in combination with DNA enrichment methods to generate deep sequencing of target genome regions, such as the exome or known disease loci, delivering fast, inexpensive, and detailed genetic information.

©2015 DNA Labs India Indias No1 Genetic DNA Testing Laboratory DNA Labs India